Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Adv Exp Med Biol ; 1354: 299-314, 2022.
Article in English | MEDLINE | ID: mdl-34807448

ABSTRACT

Dairy and beef cattle make a vital contribution to global nutrition, and since their domestication, they have been continuously exposed to natural and artificial selection to improve production characteristics. The technologies of transgenesis and gene editing used in cattle are responsible for generating news characteristics in bovine breeding, such as alteration of nutritional components of milk and meat enhancing human health benefits, disease resistance decreasing production costs and offering safe products for human food, as well as the recombinant protein production of biomedical significance. Different methodologies have been used to generate transgenic cattle as bioreactors. These methods include the microinjection of vectors in pronuclear, oocyte or zygote, sperm-mediate transgenesis, and somatic cell nuclear transfer. Gene editing has been applied to eliminate unwanted genes related to human and animal health, such as allergy, infection, or disease, and to insert transgenes into specific sites in the host genome. Methodologies for the generation of genetically modified cattle are laborious and not very efficient. However, in the last 30 years, transgenic animals were produced using many biotechnological tools. The result of these modifications includes (1) the change of nutritional components, including proteins, amino acids and lipids for human nutrition; (2) the removal allergic proteins milk; (3) the production of cows resistant to disease; or (4) the production of essential proteins used in biomedicine (biomedical proteins) in milk and blood plasma. The genetic modification of cattle is a powerful tool for biotechnology. It allows for the generation of new or modified products and functionality that are not currently available in this species.


Subject(s)
Milk , Nuclear Transfer Techniques , Animals , Animals, Genetically Modified , Bioreactors , Biotechnology , Cattle , Female
2.
Reprod Domest Anim ; 52(4): 561-569, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28295710

ABSTRACT

The aim of this study was to assess the effects of different antioxidants on the levels of reactive oxygen species (ROS) and glutathione (GSH) in oocytes during in vitro maturation (IVM), as well as on the production of embryos. Oocyte of slaughterhouse-derived cattle ovaries were placed in IVM with different antioxidants: quercetin (2 µM), cysteamine (100 µM), carnitine (0.5 mg/ml), vitamin C (50 µg/ml) or resveratrol (2 µM). Oocytes matured without any antioxidant supplementation were used as control. The oocytes were assessed for maturation rates and for ROS and GSH levels by fluorescence staining in 2',7'-dichlorodihydrofluorescein diacetate and Cell Tracker Blue, respectively. Embryo production was assessed in terms of cleavage, blastocysts and hatching rates and embryo cell numbers. The results expressed in arbitrary fluorescence units showed ROS reduction (p < .05) in the groups with quercetin (27.5 ± 3.4), vitamin C (27.1 ± 3.0) or resveratrol (28.1 ± 4.7), in comparison with those with cysteamine (34.9 ± 4.5), carnitine (34.6 ± 3.8) or to the control group (36.5 ± 5.2). GSH levels increased (p < .05) in cysteamine (63.5 ± 5.5) or carnitine (60.8 ± 4.4) groups in comparison with quercetin (52.7 ± 5.1), vitamin C (53.0 ± 3.8), resveratrol (53.1 ± 4.4) or to the control (49.6 ± 4.5). Nuclear maturation cleavage and hatched blastocysts rates did not differ (p > .05) between groups. However, blastocyst rates after in vitro fertilization in quercetin (53.5 ± 3.9%), vitamin C (52.1 ± 3.1%) resveratrol (54.2 ± 4.0%), cysteamine (52.4 ± 2.7%) or carnitine (54.2 ± 3.1%) groups were higher (p < .05) than in the control (47.2 ± 2.7%). Total cell numbers in embryos from the vitamin C, resveratrol, cysteamine or carnitine groups were higher than in quercetin and control groups, which were similar to each other. The results suggest that using antioxidants during IVM may reduce oxidative stress either by decreasing ROS levels directly or by increasing GSH levels in oocytes, depending on the type of antioxidant used. Overall, oxidative stress control during IVM with the antioxidants examined here improved blastocyst development with similar efficacy.


Subject(s)
Antioxidants/pharmacology , In Vitro Oocyte Maturation Techniques/veterinary , Oocytes/drug effects , Animals , Blastocyst/drug effects , Cattle , Embryonic Development , Female , Fertilization in Vitro/veterinary , Glutathione/analysis , In Vitro Oocyte Maturation Techniques/methods , Male , Oxidative Stress/drug effects , Reactive Oxygen Species/analysis
3.
Genet Mol Res ; 14(1): 53-62, 2015 Jan 15.
Article in English | MEDLINE | ID: mdl-25729935

ABSTRACT

Adult stem cells are known for their plasticity and their potential to differentiate into several different cell types; these characteristics have implications for cell therapy and reproductive biotechnologies. In this study, we report on the isolation and characterization of mesenchymal stem cells (MSC) derived from bovine and buffalo adipose tissue. Cells isolated using enzymatic digestion of bovine and buffalo adipose-tissue biopsy samples were grown in vitro for at least 15 passages, verifying their capacity to proliferate. These cells were also subjected to immunophenotypic characterization for the presence of CD90, CD105, and CD79, and the absence of CD45, CD34, and CD73, which are positive and negative markers of MSC, respectively. To prove their multipotency, the cells were induced to differentiate into three different cell types, chondrocytes, osteoblasts, and adipocytes, which were stained with tissue-specific dyes (Chondrogenic-Alcian Blue, Osteogenic-Alizarin Red, and Adipogenic-Oil-Red O, respectively) to confirm differentiation. Gene expression analysis of pluripotency-related genes was also conducted. Our results suggest that adipose tissue from bovines and buffalos can be used as a source of MSC, making adipose tissue-derived cells an interesting option for cell therapy and regenerative medicine. Additionally, these findings have implications for reproductive biotechnology because the use of MSC as nuclear donors has been linked to an increase in the efficiency of nuclear transfer.


Subject(s)
Adipose Tissue/cytology , Cell Separation/methods , Multipotent Stem Cells/cytology , Adipogenesis , Animals , Buffaloes , Cattle , Cell Proliferation , Chondrogenesis , Immunophenotyping , Osteogenesis
4.
Reprod Domest Anim ; 49(4): 576-583, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24891112

ABSTRACT

This study analysed two non-invasive oocyte selection methods in relation to in vitro embryo development capacity and expression of apoptosis-related genes. Selection was based on morphological quality of oocytes or follicle diameter. Oocytes were classified as grade I (GI ≥3 layers compact cumulus cells and homogeneous cytoplasm; grade II (GII ≤3 layers compact cells and homogeneous cytoplasm;, and grade III (GIII ≥3 layers, but cells with slight expansion and slightly granulated cytoplasm). Blastocyst development was lower for GII (28.5%) than for GIII (47.7%, p < 0.05), and GI was similar to both (36.9%, p > 0.05). Relative expression of Bcl-2 gene was lower in the GI (1.0, p < 0.05) than in the GII (1.8) and GIII (2.2), which were not different (p > 0.05). There was no difference (p > 0.05) between GI (1.0), GII (0.92) and GIII (0.93) regarding the Bax transcript. However, the Bax and Bcl-2 transcript ratios in GII (Bax; 0.92 and Bcl-2; 1.8) and GIII (Bax; 0.93 and Bcl-2; 2.2) were different (p < 0.05). Regarding oocytes from follicles of different sizes, cleavage and blastocyst rates for 1-3 mm (82.5; 23.7%) were lower (p < 0.05) than for 6-9 mm (95.6; 41.1%), but similar (p > 0.05) to 3-6 mm (93.7; 35.4%), which were not different (p > 0.05). Regarding Bax and Bcl-2 expression, the oocytes were similar (p > 0.05) for 1-3 mm (Bax; 1.0 and Bcl-2; 1.0), 3-6 mm (Bax; 1.0 and Bcl-2; 0.93) and 6-9 mm (Bax; 0.92 and Bcl-2; 0.91). In conclusion, oocyte selection based on morphological appearance does not guarantee the success of embryonic development. Additionally, the absence of apoptosis is not necessarily a benefit for the development of oocytes. Bovine COCs with initial signs of atresia may be used for the in vitro production of embryos, and COCs taken from follicles >3 mm in diameter are better suited to in vitro embryo development.


Subject(s)
Cattle , Genes, bcl-2 , Oocytes/growth & development , Ovarian Follicle/anatomy & histology , RNA, Messenger/analysis , bcl-2-Associated X Protein/genetics , Animals , Apoptosis/genetics , Cumulus Cells/physiology , DNA Fragmentation , Embryo Culture Techniques/veterinary , Embryonic Development , Female , Fertilization in Vitro/veterinary , Gene Expression , In Situ Nick-End Labeling , Oocytes/chemistry , Oocytes/cytology
5.
Arq. bras. med. vet. zootec ; 65(6): 1616-1624, Dec. 2013. graf, tab
Article in Portuguese | LILACS | ID: lil-696839

ABSTRACT

A quercetina é um flavonoide, amplamente encontrada em frutas, vegetais, grãos, flores, com elevada concentração no vinho tinto, e tem sido caracterizada funcionalmente pela atividade antioxidante. Para avaliação da maturação nuclear e do desenvolvimento embrionário bovino, os oócitos foram maturados por 22h na presença de quercetina (0,4, 2, 10 e 50µM), cisteamina (100µM) e na ausência dos antioxidantes. Os oócitos maturados foram corados com Hoechst para avaliação da maturação in vitro. Para avaliação do desenvolvimento embrionário, os oócitos foram fertilizados e cultivados in vitro, as taxas de desenvolvimento embrionário foram determinadas no sétimo dia de cultivo e o percentual de eclosão e o número de células dos embriões no oitavo dia. Os níveis de glutationa (GSH) dos oócitos foram mensurados por emissão de fluorescência com CMF2HC. A porcentagem de maturação nuclear (±89%) não diferiu entre os grupos. O desenvolvimento embrionário variou entre os tratamentos, o percentual de blastocisto foi superior (P<0,05) nos grupos tratados com 0,4, 2, 10 e 50∝M de quercetina (56,9, 59,5, 53,6 e 49,6%, respectivamente) e com 100∝M de cisteamina (50,4%) em relação ao grupo controle (42,3%). Na comparação entre os dois antioxidantes, a quercetina (0,4 e 2µM) foi superior na produção de embriões (56,9 e 59,5%, respectivamente) em comparação com cisteamina (50,4%). As taxas de embriões eclodidos foram similares (P>0,05) entre os grupos (±63,0%). O número médio de células dos embriões também foi similar entre os grupos (±233). Os níveis intracelulares de GSH foram superiores nos oócitos maturados com cisteamina, mas similares entre os oócitos tratados com quercetina e o controle. A suplementação da maturação in vitro com antioxidantes melhora as taxas de blastocistos. A quercetina foi superior à cisteamina, que, por sua vez, foi superior ao controle. Mas os níveis de GSH foram superiores somente nos oócitos tratados com cisteamina.


Quercetin is a flavonoid widely found in fruit, vegetables, grains and flowers, with a high concentration in red wine, and has been functionally characterized by its antioxidant activity. For assessment of nuclear maturation and bovine embryo, oocytes were matured for 22h in the presence of quercetin (0.4, 2, 10 and 50µM), cysteamine (100µM) and in the absence of antioxidants. The matured oocytes were stained with Hoechst to evaluate the in vitro maturation. To assess embryonic development, oocytes were fertilized and cultured in vitro and rates of embryo development were obtained in the seventh day of culture and the percentage of hatching and the number of cells on eighth day embryos. The levels of glutathione (GSH) of the oocytes were measured by fluorescence emission with CMF2HC. The percentage of nuclear maturation (±89%) did not differ between groups. Embryonic development varied between treatments, the percentage of blastocyst was higher (P<0.05) in the groups treated with 0.4, 2, 10 and 50∝M of quercetin (56.9, 59.5, 53.6 and 49.6%, respectively) and 100 ∝M cysteamine (50.4%) compared to the control group (42.3%). Comparing the two antioxidants, quercetin (0.4 to 2µM) was superior in embryo production (56.9 and 59.5% respectively) compared with cysteamine (50.4%). The rates of hatched embryos were similar (P>0.05) between groups (±63.0%). The average number of embryo cells was also similar in both groups (±233). The intracellular GSH levels were higher in oocytes matured with cysteamine, but similar between the oocytes treated with quercetin and control. The supplementation of matured in vitro with antioxidants improves blastocyst rates. Quercetin was greater than cysteamine, which in turn was superior to the control. However, GSH levels were higher in oocytes treated only with cysteamine.


Subject(s)
Animals , Cattle , Antioxidants , Embryo, Mammalian/embryology , Oocytes/cytology , Cattle/classification , In Vitro Oocyte Maturation Techniques
6.
Theriogenology ; 80(4): 295-301, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-23683691

ABSTRACT

Developmental competence of in vitro-matured bovine oocytes is a limiting factor in production of embryos in vitro. Several studies have suggested a potential positive effect of thyroid hormones on cultured oocytes and/or their supporting cells. Therefore, the aim of the present study was to ascertain whether medium supplementation with triiodothyronine (T3) improved subsequent developmental competence of in vitro-matured bovine oocytes. For this purpose, we first documented (using reverse transcription PCR) that whereas bovine cumulus cells expressed both thyroid hormone receptor (TR)-α and TRß, immature bovine oocytes expressed TRα only. Thereafter, to test the effects of TH on developmental competence, abattoir-derived oocytes were matured in vitro in a medium containing 0, 25, 50, or 100 nM T3 and subjected to in vitro fertilization. Embryo quality was evaluated by assessing cleavage and blastocyst rates, morphological quality, development kinetics, and total cell number on Day 8 of culture. Notably, addition of 50 or 100 nM T3 to the in vitro maturation medium increased (P < 0.05) the rate of hatched blastocysts on the eighth day of culture, as compared with other groups (62.4 ± 11.7, 53.1 ± 16.3, and 32.4 ± 5.3, respectively). Next, the relative expression levels of genes related to embryo quality POU-domain transcription factor (POU5F1) and glucose transporter-1 (GLUT 1) were compared between in vivo- and in vitro-produced blastocysts. On the basis of the previous experiments, IVP embryos originating from oocytes that were matured in vitro in the presence or absence of 50 nM T3 were evaluated. The treatment had no effect (P > 0.05) on gene expression. We concluded that supplementation of bovine oocyte in vitro maturation medium with T3 may have a beneficial effect on the kinetics of embryo development.


Subject(s)
In Vitro Oocyte Maturation Techniques/methods , Oocytes/drug effects , Oogenesis/drug effects , Triiodothyronine/pharmacology , Animals , Cattle , Cells, Cultured , Cumulus Cells/drug effects , Cumulus Cells/physiology , Embryonic Development/drug effects , Embryonic Development/genetics , Female , Gene Expression Regulation, Developmental/drug effects , In Vitro Oocyte Maturation Techniques/veterinary , Male , Oocytes/physiology , Oogenesis/genetics , Receptors, Thyroid Hormone/genetics , Receptors, Thyroid Hormone/metabolism
7.
Reprod Domest Anim ; 46(1): e31-8, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20403123

ABSTRACT

This study aimed at assessing the effect of the addition of brain-derived neurotrophic factor (10 ng/ml BDNF) and/or cysteamine (100 µm CYS) during pre-maturation and BDNF, CYS or leptin (10 ng/ml LEP) during maturation culture in vitro on embryo development and oocyte gene expression in cattle. Oocytes were obtained by the aspiration of 2- to 8-mm follicles from slaughtered cows. In Experiment 1, oocytes were pre-matured for 24 h with 10 µm butyrolactone I in the presence or not of BDNF and/or CYS followed by in vitro maturation (IVM), fertilization (IVF) and culture (IVC). In Experiment 2, oocytes were submitted to IVM with BDNF, CYS or LEP or no supplements followed by IVF and IVC. In Experiment 3, oocytes were pre-matured with BDNF and CYS followed by IVM or only in vitro matured with BDNF. Samples for quantitative PCR (qPCR) were collected after pre-maturation (BGV) and after IVM of pre-matured oocytes (BMII) or immediately after follicle aspiration (immature control = GV) and IVM (matured control = MII). Embryo production was not affected by the inclusion of the different factors either during pre-maturation or maturation culture (∼ 43% blastocysts, p>0.05). Transcripts analysis showed that most genes (NLRP5, ZAR1, GPX1, KEAP1, SPHK2, HSP70 and PSMP1) were downregulated (p<0.05) after IVM irrespective of being previously pre-matured. The relative abundance of BAX, BCL2, IGFBP3 and ARFRP1 transcripts was unaffected by pre-maturation or maturation (p>0.05). In conclusion, supplementation of in vitro pre-maturation (BDNF and/or CYS) or maturation media (BDNF, CYS or LEP) did not improve embryo development. Gene expression was not affected by pre-maturation treatment, but some genes were downregulated after maturation, probably related to selective and differential degradation.


Subject(s)
Cattle , Culture Media , Embryo Culture Techniques/veterinary , Embryonic Development , Gene Expression , Oocytes/metabolism , Animals , Brain-Derived Neurotrophic Factor/administration & dosage , Cattle/embryology , Cells, Cultured , Cysteamine/administration & dosage , Embryonic Development/drug effects , Female , Fertilization in Vitro/veterinary , Gene Expression/drug effects , Leptin/administration & dosage , Oocytes/drug effects , Oocytes/growth & development , Polymerase Chain Reaction
8.
Reprod Domest Anim ; 45(1): 75-80, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20137060

ABSTRACT

The importance of nitric oxide synthase (NOS) in bovine oocyte maturation was investigated. Oocytes were in vitro matured with the NOS inhibitor N(w)-L-nitro-arginine methyl-ester (10(-7), 10(-5) and 10(-3) m L-NAME) and metaphase II (MII) rates and embryo development and quality were assessed. The effect of L-NAME (10(-7) m) during pre-maturation and/or maturation on embryo development and quality was also assessed. L-NAME decreased MII rates (78-82%, p < 0.05) when compared with controls without L-NAME (96%). Cleavage (77-88%, p > 0.05), Day 7 blastocyst rates (34-42%, p > 0.05) and total cell numbers in blastocysts were similar for all groups (146-171 cells, p > 0.05). Day 8 blastocyst TUNEL positive cells (3-4 cells) increased with L-NAME treatment (p < 0.05). For oocytes cultured with L-NAME during pre-maturation and/or maturation, Day 8 blastocyst development (26-34%) and Day 9 hatching rates (15-22%) were similar (p > 0.05) to controls pre-matured and matured without NOS inhibition (33 and 18%, respectively), while total cell numbers (Day 9 hatched blastocysts) increased (264-324 cells, p < 0.05) when compared with the controls (191 cells). TUNEL positive cells increased when NOS was inhibited only during the maturation period (8 cells, p < 0.05) when compared with the other groups (3-4 cells). NO may be involved in meiosis progression to MII and its deficiency during maturation increases apoptosis in embryos produced in vitro. Nitric oxide synthase inhibition during pre-maturation and/or maturation affects embryo quality.


Subject(s)
Cattle , Embryonic Development/drug effects , Enzyme Inhibitors/pharmacology , Meiosis/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Oocytes/physiology , Animals , Blastocyst/cytology , Blastocyst/drug effects , Blastocyst/physiology , Cell Count , Female , Fertilization in Vitro/veterinary , In Situ Nick-End Labeling , Male , Metaphase/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Oocytes/cytology
9.
Reprod Domest Anim ; 45(6): 1074-81, 2010 Dec.
Article in English | MEDLINE | ID: mdl-19602178

ABSTRACT

This study aimed to assess the effects of cyclin-dependent kinase (CDK) inhibition on factors involved in the control of meiosis in bovine oocytes: maturation promoting factor (MPF) (p34(cdc2) and cyclin B1) and mitogen activated protein kinase (MAPK). Oocytes were maintained at germinal vesicle (GV) stage in vitro with 10 µM of the CDK inhibitor butyrolactone I (BLI) for 24 h (inhibited). After this period, some of the oocytes were transferred to in vitro maturation (IVM) culture for 24 h (inhibited and matured). Control oocytes were assessed immediately after follicle aspiration (immature) or after in vitro maturation for 24 h (matured). Real-time PCR analyses showed that transcripts for p34(cdc2) and MAPK were detected in immature and inhibited oocytes and decreased after maturation, irrespective of CDK inhibition with BLI. Cyclin B1 was detected at similar levels in all oocyte groups. The p34(cdc2) and MAPK proteins were detected by Western blotting at similar levels in all oocyte groups, and cyclin B1 protein was detected only after maturation. Immunofluorescence detection showed that p34(cdc2) was localized in the cytoplasm and GV of immature oocytes, and then throughout the cytoplasm after maturation. Cyclin B1 and MAPK were detected in the cytoplasm in all oocyte groups. Maturation promoting factor and MAPK activities were similar throughout most of maturation for oocytes treated with or without BLI. In conclusion, CDK inhibition did not affect the expression (mRNA and protein levels) and localization of MPF and MAPK, and had nearly no effect on kinase activities during maturation.


Subject(s)
4-Butyrolactone/analogs & derivatives , Cattle/physiology , Gene Expression Regulation/drug effects , Maturation-Promoting Factor/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Oocytes/drug effects , 4-Butyrolactone/pharmacology , Animals , Cyclin B1/genetics , Cyclin B1/metabolism , Cyclin-Dependent Kinases/antagonists & inhibitors , Maturation-Promoting Factor/genetics , Oocytes/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism
10.
Anim Reprod Sci ; 116(3-4): 233-43, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19327921

ABSTRACT

Nitric oxide (NO) is a chemical messenger generated by the activity of the nitric oxide synthases (NOS). The NOS/NO system appears to be involved in oocyte maturation, but there are few studies on gene expression and protein activity in oocytes of cattle. The present study aimed to investigate gene expression and protein activity of NOS in immature and in vitro matured oocytes of cattle. The influence of pre-maturation culture with butyrolactone I in NOS gene expression was also assessed. The following experiments were performed: (1) detection of the endothelial (eNOS) and inducible (iNOS) isoforms in the ovary by immunohistochemistry; (2) detection of eNOS and iNOS in the oocytes before and after in vitro maturation (IVM) by immunofluorescence; (3) eNOS and iNOS mRNA and protein in immature and in vitro matured oocytes, with or without pre-maturation, by real time PCR and Western blotting, respectively; and (4) NOS activity in immature and in vitro matured oocytes by NADPH-diaphorase. eNOS and iNOS were detected in oocytes within all follicle categories (primary, secondary and tertiary), and other compartments of the ovary and in the cytoplasm of immature and in vitro matured oocytes. Amount of mRNA for both isoforms decreased after IVM, but was maintained after pre-maturation culture. The NOS protein was detected in immature (pre-mature or not) and was still detected in similar amount after pre-maturation and maturation for both isoforms. NOS activity was detected only in part of the immature oocytes. In conclusion, isoforms of NOS (eNOS and iNOS) are present in oocytes of cattle from early folliculogenesis up to maturation; in vitro maturation influences amount of mRNA and NOS activity.


Subject(s)
Cattle/metabolism , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide Synthase Type II/metabolism , Oocytes/metabolism , Animals , Cattle/genetics , Cell Differentiation/genetics , Cell Differentiation/physiology , Cells, Cultured , Enzyme Activation , Female , Gene Expression Regulation, Enzymologic , Isoenzymes/genetics , Isoenzymes/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type III/genetics , Oocytes/enzymology , Oogenesis/genetics , Oogenesis/physiology , Ovarian Follicle/enzymology , Ovarian Follicle/metabolism , Ovarian Follicle/physiology , RNA, Messenger/metabolism
11.
Theriogenology ; 71(5): 836-48, 2009 Mar 15.
Article in English | MEDLINE | ID: mdl-19121865

ABSTRACT

Oocyte maturation is a long process during which oocytes acquire their intrinsic ability to support the subsequent stages of development in a stepwise manner, ultimately reaching activation of the embryonic genome. This process involves complex and distinct, although linked, events of nuclear and cytoplasmic maturation. Nuclear maturation mainly involves chromosomal segregation, whereas cytoplasmic maturation involves organelle reorganization and storage of mRNAs, proteins and transcription factors that act in the overall maturation process, fertilization and early embryogenesis. Thus, for didactic purposes, we subdivided cytoplasmic maturation into: (1) organelle redistribution, (2) cytoskeleton dynamics, and (3) molecular maturation. Ultrastructural analysis has shown that mitochondria, ribosomes, endoplasmic reticulum, cortical granules and the Golgi complex assume different positions during the transition from the germinal vesicle stage to metaphase II. The cytoskeletal microfilaments and microtubules present in the cytoplasm promote these movements and act on chromosome segregation. Molecular maturation consists of transcription, storage and processing of maternal mRNA, which is stored in a stable, inactive form until translational recruitment. Polyadenylation is the main mechanism that initiates protein translation and consists of the addition of adenosine residues to the 3' terminal portion of mRNA. Cell cycle regulators, proteins, cytoplasmic maturation markers and components of the enzymatic antioxidant system are mainly transcribed during this stage. Thus, the objective of this review is to focus on the cytoplasmic maturation process by analyzing the modifications in this compartment during the acquisition of meiotic competence for development.


Subject(s)
Cattle , Cytoplasm/chemistry , Cytoplasm/physiology , Oocytes/ultrastructure , Animals , Cytoskeleton/physiology , Cytoskeleton/ultrastructure , Female , Meiosis , Oocytes/growth & development , Oocytes/metabolism , Organelles/physiology , Organelles/ultrastructure , RNA, Messenger/genetics , RNA, Messenger/metabolism
12.
Anim Reprod Sci ; 104(2-4): 389-97, 2008 Mar 03.
Article in English | MEDLINE | ID: mdl-17644285

ABSTRACT

Cyclin dependent kinase inhibitors (CDKIs) may be used for pre-maturation culture, but can accelerate nuclear maturation. The aim of the present research was to compare the effect of butyrolactone I (BLI) alone or combined with roscovitine (ROS) at lesser than typically used concentrations on nuclear maturation kinetics and embryo development. To assess maturation kinetics (Experiment 1), oocytes were cultured in 100 microM BLI (B) or 6.25 microM BLI+12.5 microM ROS (BR) in TCM-199 for 24 h. Oocytes were subsequently submitted to in vitro maturation (IVM) in TCM-199+0.5 microg/ml FSH, 50 microg/ml LH and 10% FCS for another 24 h, during which oocytes were fixed every 3 h. In Experiment 2, oocytes were submitted to 24h pre-maturation treatments, with the inhibitors being diluted in TCM-199 or DMEM. IVM lasted 21 h in the culture media DMEM+0.5 microg/ml FSH, 50 microg/ml LH, 5% FCS and 50 ng/ml EGF. After IVM, oocytes from all groups were fertilized in vitro. Oocytes and sperm (2x10(6) sperm cells/ml) were co-cultured for 18 h. Embryos were co-cultured with granulosa cells in CR2aa for 8 days. All cultures were in droplets under oil, at 38.5 degrees C and 5% CO2 in air. In both experiments, control oocytes (C) were submitted only to IVM. In Experiment 1, at 0 h, C and B oocytes were all (100%) at the germinal vesicle stage (GV) of development. BR had fewer GV oocytes (89%, P<0.05). After 3 h IVM, B and BR had fewer oocytes in GV (84.7 and 79.6%, P>0.05) than C (100%, P<0.05). At 12 h, most oocytes were at intermediate stages (metaphase to telophase I) in all groups (approximately 80%, P>0.05). After 21 (77-89%) and 24 h (85-95%), all groups had similar metaphase II (MII) rates of development (P>0.05). In Experiment 2, cleavage (79-84%, P>0.05) and Day 7 blastocyst rates (26-36%, P>0.05) were similar. After 8 days, the group pre-matured with BR in DMEM had lesser blastocyst rates of development (32.3%) lower than C (40.1%, P<0.05). The other groups were similar to C (35-38%, P>0.05). Hatching rates were similar (10-15%, P>0.05) as were total cell numbers (141-170). In conclusion, BR is less effective in maintaining meiosis block; B and BR accelerate meiosis resumption; and use of pre-maturation medium may affect developmental rates.


Subject(s)
4-Butyrolactone/analogs & derivatives , Cattle/embryology , Embryonic Development/physiology , Oocytes/physiology , Protein Kinase Inhibitors/pharmacology , Purines/pharmacology , 4-Butyrolactone/pharmacology , Animals , Cell Culture Techniques/veterinary , Culture Media , Embryonic Development/drug effects , Female , Fertilization in Vitro/veterinary , Male , Pregnancy , Roscovitine
13.
Theriogenology ; 66(6-7): 1465-7, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16875725

ABSTRACT

In vitro studies that use isolated oocytes benefit from the ability to harvest oocytes of excellent morphological quality in sufficient numbers to allow the replicability of techniques and experiments. The objective of the present study was to verify the effect of the age of the donor bitch on the quantity and quality of oocytes recovered from isolated ovaries, using the slicing technique. Ten bitches (45 days to 13 years) were ovariohysterectomized, and the ovaries were placed in phosphate buffered saline (PBS), supplemented with bovine fetal serum (5%), and oocyte-cumulus-complexes (OCCs) were obtained by slicing the ovarian tissue. The OCSs were classified morphologically as Degree I (DI, best), Degree II (DII) and degenerated. A total of 427 oocytes were acquired, including 81, 109 and 237 that were graded as DI, DII and degenerated, respectively. Slicing yielded no OCS from animals < 2 months of age. In senile (> 9 years) bitches, bitches, there were more oocytes per bitch, compared to adult (2-6.5 years) bitches, but fewer DI oocytes, and more DII and degenerate oocytes. We inferred that using donors that were post-pubertal but not senile, would assure the recovery of high-quality oocytes by the slicing method. Additional studies are required to assess the quality of oocytes collected from pre-pubertal versus post-pubertal bitches < 2 years of age.


Subject(s)
Dogs/physiology , Oocyte Donation/veterinary , Oocytes/physiology , Age Factors , Animals , Female , Oocyte Donation/standards
14.
Arq. bras. med. vet. zootec ; 58(3): 354-359, jun. 2006. tab
Article in English | LILACS | ID: lil-443588

ABSTRACT

The effect of concentration and exposure period of bovine oocytes to butyrolactone I (BLI) on meiotic block and in vitro maturation (IVM) kinetics was studied. In experiment 1, all oocytes were at germinal vesicle stage (GV), after 6h in culture with 0, 50 and 100æM BLI. After 12h, all oocytes cultured with 50 and 100æM BLI remained in GV. After 24h, less oocytes were in GV with 50æM (82 percent) than with 100æM BLI (99 percent, P<0.05). In experiment 2, after 6h IVM, 93 percent of control oocytes (IVM only) were in GV, while treated oocytes (100æM BLI for 6, 12 or 24h prior to IVM) showed less oocytes in GV with increased exposure period to BLI prior to IVM (83 and 73 percent, for 6h and 12h, P<0.05). For a 24h inhibition, GV rates were similar to 12h (70 percent, P>0.05). After 18h IVM, metaphase II (MII) rates were similar for all groups (76-81 percent). In experiment 3, after 6h IVM, 74 percent of treated oocytes (50 or 100æM BLI for 12h) were in GV. This rate was lower than for control oocytes (97.3 percent, P<0.05). After 18h IVM more oocytes (~80 percent, P>0.05) were in MII with BLI than for control (73 percent, P<0.05). Shorter culture periods require lower BLI concentration for meiotic block; initial nuclear maturation kinetics of oocytes cultured with BLI is accelerated, and this is affected by culture period but not by drug concentration.


Estudou-se o efeito da concentração e do tempo de exposição à butirolactona I (BLI) no bloqueio meiótico e na cinética da maturação in vitro (MIV) de oócitos bovinos. No experimento 1, todos os oócitos encontravam-se em vesícula germinativa (VG) após 6h de cultivo nas concentrações de 0,50 e 100æM BLI. Após 12h, somente oócitos cultivados com BLI (50 e 100æM) estavam em VG. Após 24h, menos oócitos tratados com 50æM (82 por cento) estavam em VG em relação a 100æM (99 por cento, P<0,05). No experimento 2, após 6h de MIV, 93 por cento dos controles (somente MIV) estavam em VG, enquanto que nos tratados (100æM BLI por 6, 12 ou 24h pré-MIV), menor proporção de oócitos permaneceu nesse estádio com o aumento do tempo de exposição à BLI antes da MIV (83 e 73 por cento para 6 e 12h, P<0,05). Com 24h de exposição, a taxa de VG foi similar à de 12h (70 por cento, P>0,05). A taxa de metáfase II (MII, 76-81 por cento) foi similar para todos os tempos de exposição, após 18h de MIV. No experimento 3, após 6h de MIV, menos oócitos tratados (74 por cento para 50 ou 100æM BLI por 12h) estavam em VG comparados aos controles (97 por cento, P<0,05). Após 18h de MIV, mais oócitos estavam em MII com BLI (~80 por cento, P>0,05) do que os controles (73 por cento, P<0.05). Conclui-se que para cultivos mais curtos, a concentração mais baixa de BLI bloqueia a meiose a cinética da maturação nuclear é acelerada em oócitos expostos à BLI e isso é afetado pelo tempo de cultivo, mas não pela concentração da droga.


Subject(s)
/administration & dosage , Cattle , Meiosis/physiology , Oocytes/physiology
15.
Anim Reprod Sci ; 65(3-4): 171-80, 2001 Mar 30.
Article in English | MEDLINE | ID: mdl-11267797

ABSTRACT

Several reports have suggested that a treatment before in vitro maturation might improve oocyte competence and increase its developmental potential. Therefore, the objectives of the present study were to establish the kinetics of IVM in Zebu oocytes, to assess the effect of 6-dimethylaminopurine (6-DMAP), a phosphorylation inhibitor, on meiotic resumption, and to verify the developmental potential of the blocked oocytes after removal of the inhibitory conditions. To establish the kinetics of in vitro maturation 1422 oocytes were obtained from Nellore cows ovaries and matured in presence and absence of gonadotropins. Samples of oocytes were taken from culture at 0, 6, 9, 12, 15, 18, 21 and 24h, and the oocytes were fixed, stained and evaluated for nuclear morphology. Germinal vesicle break down (GVBD) occurred between 6 and 12h of culture in both groups. By 21h the majority of the oocytes had reached metaphase II in presence (71%) and absence (62%) of gonadotropins. In order to examine the inhibitory effect of 6-DMAP, 585 oocytes were cultured for 12, 18 and 24h in the presence or absence of 2mM of 6-DMAP. At each time point the oocytes were evaluated for nuclear morphology. To test the reversibility of meiotic inhibition 366 oocytes were incubated for 0, 12, 18 and 24h in the presence of 6-DMAP and then were transferred to the maturation medium and cultured for further 24h. A total of 429 oocytes were used to evaluate the developmental potential after meiotic inhibition. The oocytes were cultured in the presence of 6-DMAP for 0, 12, 18 and 24h, and then were matured, fertilized and cultured in vitro. Culture of bovine oocytes in the presence of 6-DMAP up to 24h completely blocked GVBD with more than 90% of the oocytes at GV stage. The inhibitory effect of 6-DMAP was fully reversible since maturation rates were similar (P>0.05) among all treatment groups. The evaluation of embryo development after various periods of meiotic blockage showed that inhibition, regardless the time period, had no effect (P>0.05) on penetration and cleavage rates. However, the proportion of embryos at blastocyst stage was reduced after inhibition for 12 (20.2%), 18 (20.1%) and 24h (19.0%) compared with the control group (35.6%). 6-DMAP has a reversible effect on maintenance of meiotic arrest, but reduced further embryo development.


Subject(s)
Adenine/analogs & derivatives , Adenine/pharmacology , Enzyme Inhibitors/pharmacology , Meiosis/drug effects , Oocytes/cytology , Oocytes/physiology , Animals , Cattle , Cells, Cultured , Female , Oocytes/drug effects , Ovarian Follicle/cytology , Phosphorylation , Protein Kinase Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...